Healthcare -
Biotechnology - NASDAQ - US
$ 13.78
3.07 %
$ 516 M
Market Cap
9.57
P/E
TRDA - LONG-TERM DEBT
Long-term Debt TRDA - Entrada Therapeutics, Inc.
60.3 M
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR